BIBW 2992 (Afatinib) in Head & Neck Cancer

Clinical trial NCT00514943 · COMPLETED

Trial details

NCT number: NCT00514943
Sponsor: Boehringer Ingelheim
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Head and Neck Neoplasms Carcinoma, Squamous Cell

Start date: 2007-08-01
Primary completion: 2010-03-01
Enrollment: 124

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.